肾素血管紧张素系统一直是人们研究的热点，现就肾素血管紧张素系统的组成成分、代谢途径及其生物学作用作一介绍。
Renin angiotensin system has been a hot point in studying. In this text, we will introduce the constituents, metabolic pathways and biological effects of the renin angiotensin system.
结论肾素血管紧张素醛固酮系统激活是甲亢性心脏病发病的重要原因之一。
Conclusion Hyperthyroidism results in activation of renin angiotensin aldosterone system which contributes to the pathogenesis of hyperthyroid heart disease.
丙泊酚抑制肾素血管紧张素系统可能是其对血液动力学抑制的机制之一。
Propofol can inhibit rennin angiotensin system, which may be one of the mechanisms responsible for hemodynamic depression of propofol.
开心胶囊可以抑制胶原蛋白的合成，增加心肌顺应性。 对肾素—血管紧张素—醛固酮系统的影响可能是其作用机制之一。
KC can inhibit the production of collagen and increase myocardial compliance and its mechanism may be involved in the regulation of rennin angiotensin aldosterone system.
存在一个脑肾素血管紧张素系统(RAS)是假设30年前。
The existence of a brain renin-angiotensin system (RAS) was postulated 30 years ago.
肾素血管紧张素系统是生理功能颇为复杂的内分泌系统，广泛存在于机体各个组织。
Renin angiotensin system is an endocrine system with complex physiological functions, existing in many tissues.
肾素-血管紧张素系统作用机制的第一步是肾近球细胞受到低血压、交感神经兴奋、低血容量及低钠流量的刺激而分泌肾素。
The first step in the RAS cascade is the secretion of the enzyme renin by renal juxtaglomerular cells in response to low blood pressure, sympathetic activation, hypovolemia, and low sodium flux.
肾素-血管紧张素-醛固酮系统（RAAS）是一种能被容量丢失激活的反馈控制系统。
The renin-angiotensin-aldosterone system (RAAS) is a feedback system activated with volume depletion.
肾素抑制剂是一种通过在一系列活动中高效抑制肾素—血管紧张素系统（RAS）而发挥作用的新型抗高血压药物。
Renin inhibitors are a new class of antihypertensive agents that act by blocking the renin-angiotensin system (RAS) at the highest level in the chain of events.
目前，我认为血管紧张素受体阻断剂是耐受更好的肾素-血管紧张素系统阻滞剂，因此我会在联合策略中包括这种药物。
I think at the moment, the angiotensin receptor blockers are the better tolerated blockers of the renin-angiotensin system, so I would include those in a combination.
结论：清热降压颗粒是治疗青壮年原发性高血压心肝火旺证的有效复方，其降压机制可能与抑制肾素-血管紧张素系统活性有关。
Conclusion: the QRAG is a group of effective drugs treating EH of youth and middle age. Its mechanism of action may have the relation of inhibiting RAS 'activity.
结论：清热降压颗粒是治疗青壮年原发性高血压心肝火旺证的有效复方，其降压机制可能与抑制肾素-血管紧张素系统活性有关。
Conclusion: the QRAG is a group of effective drugs treating EH of youth and middle age. Its mechanism of action may have the relation of inhibiting RAS 'activity.
应用推荐